Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke "ROTEMPredict"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Patient (> 18 years) with a neurological deficit compatible with a neurovascular pathology eligible for fibrinolysis rtPA and having a proximal occlusion of the middle cerebral artery (segment M1 / M2) or basilar trunk objectified brain imaging (MRI angiography or angio CT).

Exclusion Criteria

- Any patient with major comorbidity, a pathology of hemostasis or anticoagulant treatment (vitamin K antagonist (VKA), direct oral anticoagulant).